Professional Documents
Culture Documents
A Mathematical Model and Analysis of An SVEIR Mode
A Mathematical Model and Analysis of An SVEIR Mode
Email address:
Received: October 16, 2019; Accepted: November 28, 2019; Published: February 19, 2020
Abstract: In this paper, the dynamics of SVEIR model with saturated incidence force of infection and saturated
vaccination function for Streptococcus pneumonia (that is, model that monitors the temporal transmission dynamics of
the disease in the presence of preventive vaccine) was formulated and analyzed. The basic reproduction number that
determines disease extinction and disease survival was revealed. The existing threshold conditions of all kinds of the
equilibrium points are obtained and proved to be locally asymptotic stable for disease-free equilibrium using
linearization method and Lyapunov functional method for Endemic equilibrium. Qualitative Analysis of the model was
obtained and the positive of solution obtained. It was revealed that the model is positively –invariant and attracting. Thus
the region is positively invariant. Hence, it is sufficient to consider the dynamics of the model (1) in the given region. In
this region, the model can be considered as been epidemiologically and mathematically well-posed. The governing model
was normalized and also Adomian Decomposition method was used to compute an approximate solution of the non-
linear system of differential equations governing the model. Maple was used in carrying out the simulations (numerical
solutions) of the model. Graphical results were presented and discussed to illustrate the solution of the problem. The
achieved results reveal that the disease will die out within the community if the vaccination coverage is above the critical
vaccination proportion. The study indicates that we should improve the efficiency and enlarge the capacity of the
treatment to control the spread of disease.
Keywords: Mathematical Model, SVEIR Model, Streptococcus Pneumonia, Saturated Incidence Force Ofinfection
Now we have
N (t ) = S (t ) + V (t ) + E (t ) + I (t ) + R(t )
Applying the symbols and parameters, assumptions and flow diagram, we now formulate the model equations as follows:
dS βI
= (1 − p ) Λ + ωΛ + ρ R − S − µS
dt 1+ α I
dV β (1 − ξ )VI
= pΛ − − ( µ + ω )V
dt 1+ α I
βI β (1 − ξ )VI
dE
= S+ − (µ + σ )E (4)
dt 1 + α I 1+α I
dI
= σ E − (µ + ε + γ )I
dt
dR
= γ I − (σ + ρ ) R
dt
Mathematical Modelling and Applications 2020; 5(1): 16-38 19
βI
Where λ = is the saturated incidence force of infection.
1+α I
3. Qualitative Analysis
3.1. Positivity of Solutions
We prove the positivity of the solution by stating and proving the Theorem 3.1 below.
Theorem 3.1:
Suppose we have the initial solution of our model to be {S (0), V (0), E (0), I (0), R (0) ≥ 0} ∈ ϕ . Then for all t ≥ 0 the solution
set {S (t ), V (t ), E (t ), I ( t ), R ( t )} the system (3) remains positive
Proof:
From the first equation of (3) we have
dS dS
≥ −µ S ⇒ ≥ − µ dt
dt S
⇒ ln S ≥ − µ t + c ⇒ S ≥ e − µ t + c = S 0 e − µ t ≥ 0 where S 0 = e c
dV
≥ − ( µ + ω )V
dt
dV
⇒ ≥ ( µ + ω ) dt ⇒ ln V ≥ ( µ + ω )t + c ⇒ V ≥ e ( µ + ω ) t + c = V0 e ( µ + ω ) t where V0 = e c
V
dE dE
≥ −( µ + σ ) E ⇒ ≥ − ( µ + σ ) dt
dt E
⇒ ln E ≥ − ( µ + σ )t + c ⇒ E ≥ e − ( µ + σ ) t + c = E 0 e − ( µ + σ ) where E 0 = e c
dI dI
≥ −( µ + ε + γ ) I ⇒ ≥ −( µ + ε + γ )dt
dt I
⇒ ln I ≥ − ( µ + ε + γ )t + c ⇒ I ≥ e − ( µ + ε +γ )t + c = I 0 e − ( µ +ε +γ )t where I 0 = ec
dR dR
≥ −(µ + ρ ) R ⇒ ≥ − ( µ + ρ ) dt
dt R
ln R ≥ − ( µ + ρ ) t + c ⇒ R ≥ e − ( µ + ρ ) t + c = R0 e − ( µ + ρ ) where R0 = e c
Hence the solution set {S (t ), V (t ), E (t ), I ( t ), R ( t )} of the system (3) is positive for all t ≥ 0 .
Remark 1: > 0 for all real values of k.
Theorem 3.2 (Invariant Region)
The following feasible region of the model (3)
Λ
Ω = ( S , V , E , I , R ) ∈ R 5+ : S + V + E + I + R ≤
µ
20 Opara Chiekezi Zephaniah et al.: A Mathematical Model and Analysis of an SVEIR Model for Streptococcus
Pneumonia with Saturated Incidence Force of Infection
dN dS dV dE dI dR
S +V + E + I + R = N ⇒ = + + + +
dt dt dt dt dt dt
dN
= Λ − µ S − µV − µ E − µ I − µ R = Λ − µ ( S + V + E + I + R ) = Λ − µ N
dt
dN
∴ = Λ − µN
dt
dN dN d Λ ce − µ Λ
⇒ = Λ − µN ⇒ + µ N = Λ ⇒ ( µ N ) = Λ + ce − µ ⇒ N = + ⇒ N ≤ ≥0
dt dt dt µ µ µ
Λ
∴ Ω = ( S , V , E , I , R ) ∈ ℜ 5+ : S + V + E + I + R ≤
µ
dS dV dE dI dR
= = = = =0
dt dt dt dt dt
βI
(1 − p ) Λ + ω Λ + ρ R − S − µS = 0 (5)
1+ α I
β (1 − ξ )VI
pΛ − − ( µ + ω )V = 0 (6)
1+α I
βI β (1 − ξ )VI
S+ − (µ + σ ) E = 0 (7)
1+ α I 1+ α I
σ E − (µ + ε + γ ) I = 0 (8)
γ I − (σ + ρ ) R = 0 (9)
βI (1 − p)Λ + ωV * + ρ R*
(1 − p)Λ + ωΛ + ρ R − S − µS ⇒ S* = (10)
1+ α I (λβ I * + µ )
From (8)
β (1 − ξ )VI
pΛ − − ( µ + ω )V = 0 ⇒ p Λ (1 + α I ) = β (1 − ξ )VI − ( µ + ω )(1 + α I )V
1+α I
pΛ
⇒V* = (11)
λβ (1 − ξ ) I * − ( µ + ω )
From (9)
Mathematical Modelling and Applications 2020; 5(1): 16-38 21
βI β (1 − ξ )VI λβ I *[ S * + (1 − ξ )V * ]
S+ − (µ + σ )E = 0 ⇒ E * = (12)
1+ α I 1+ α I (µ + σ )
From (10)
σ E*
σ E − (µ + ε + γ ) I = 0 ⇒ I * = (13)
(µ + ε + γ )
From (11)
γ I*
γ I − (σ + ρ ) R = 0 ⇒ R* = (14)
(µ + ρ )
(
ξ 0 = S * , 0, 0, 0, 0 ) (15)
(
ξ E = S * , V * , E * , I * , R* ) (16)
(1 − p)Λ + ωV * + ρ R*
S* =
(λβ I * + µ )
pΛ
V* =
λβ (1 − ξ ) I * − ( µ + ω )
λβ I *[ S * + (1 − ξ )V * ] (17)
E =
*
(µ + σ )
σE *
I* =
(µ + ε + γ )
γI *
R* =
(µ + ρ )
and
where
(σ + µ )E
∂f (ξ 0 ) ∂v (ξ 0 ) v( x) =
Fi = i and Vi = i ( µ + ε + γ ) I − σ E
∂X j ∂X j
Then F and V which are the Jacobian of f andv evaluated
fi is the rate of appearance of new infection in at the DFE ξ 0 respectively becomes
compartment i and vi = vi − − vi +
0 β ( S 0 + (1 − ξ )V 0 )
vi − is the transfer of individuals out of the compartment i , F (ξ 0 ) =
0 0
+
vi is the rate of transfer into compartment i by any other
means, σ + µ 0
V (ξ 0 ) =
ξ 0 is the disease free equilibrium −σ µ +ε +γ
Then by linearizing fi and vi , and evaluating at the
Hence we compute V −1 and obtain
disease free equilibrium point we obtain the associated
matrices Fi and Vi respectively.
The infected compartments are, E and I hence a
1 µ +ε +γ 0
V −1 (ξ 0 ) =
(σ + µ )( µ + ε + γ ) σ σ +µ
σβ ( S 0 + (1 − ξ )V 0 ) β ( S 0 + (1 − ξ )V 0 )
1 0 β ( S 0 + (1 − ξ )V 0 ) µ + ε + γ 0
FV −1
=
= (σ + µ )( µ + ε + γ ) µ +ε +γ
(σ + µ )( µ + ε + γ ) 0 0 σ σ + µ
0 0
The basic reproduction number is given by R0 = ρ ( FV −1) , that is, the highest eigenvalue of FV −1 is
Hence
σβ Λ[ µ (1 − pξ ) + ω ]
R0 = (18)
µ ( µ + ω )(σ + µ )( µ + ε + γ )
Theorem 3.3: The disease free equilibrium (ξ 0 ) is locally asymptotically stable if R0 < 1 and unstable if R0 > 1
Proof:
We prove the locally asymptotically stability of the disease free equilibrium ( E 0 ) of model (1) using linearization approach.
We linearize the model equation to obtain the Jacobian matrix:
(λβ + µ ) ω 0 −λβ S ρ
0 −λβ (1 − ξ ) I ( µ + ω ) 0 λβ (1 − ξ )V 0
J= λβ I λβ (1 − ξ ) I −( µ + σ ) λβ S + λβ (1 − ξ )V 0
0 0 σ −( µ + ε + γ ) 0
0 0 0 γ −( µ + ρ )
(1 − ρ ) ω 0 −λβ S ρ
0 −λβ (1 − ξ ) I ( µ + ω ) 0 λβ (1 − ξ )V 0
J = λβ I λβ (1 − ξ ) I −( µ + σ ) λβ S + λβ (1 − ξ )V 0
0 0 σ −( µ + ε + γ ) 0
0 0 0 γ −( µ + ρ )
−β
λ + k1 ω 0
µ 1
k −ρ
0 −( µ + ω ) − λ 0 β k1 0
J − λI = −β =0
0 0 −( µ + σ ) − λ (k1 + µ k1 ) 0
µ
0 0 σ λ + (µ + ε + γ ) 0
0 0 0 γ −( µ + ρ ) − λ
Λω + Λµ (1 − ρ ) (1 − ξ )Λp
k1 = , k2 =
(µ + ω ) (µ + ω )
αβ
where (k1 − λ )[( µ + ω ) − λ ][( µ + ρ ) − λ ][λ 2 + (2µ + σ + ξ + γ )λ + ( µ + σ )( µ + ξ + γ ) − (k1 + µ k2 )] = 0
µ
Obviously,
αβ
λ1 = k1 , λ2 = −( µ + ω ), λ3 = −( µ + ρ ) and λ 2 + (2 µ + σ + ξ + γ )λ + [( µ + σ )( µ + ξ + γ ) − (k1 + µ k2 ) = 0]
µ
αβ
Letting A2 = 1, A1 = 2µ + σ + ξ + γ and A0 = ( µ + σ )( µ + ξ + γ ) − (k + µ k2 ), we obtain the equation
µ 1
(19)
A2 λ 2 + A1λ + A0 = 0
Using the Routh-Hurwitz stability criterion according to [32]which state that all the roots of the characteristics equation (19)
above have negative real parts if and only if the co-efficient Ai are positive and matrices Hi > 0 for i = 0,1, 2
Hence from (18) we see that
A2 = 1 > 0; A1 = 2µ + σ + ξ + γ > 0
And
σβ [ ∧ω + λµ (1 − ξρ )]
A0 = ( µ + σ )( µ + ξ + γ ) −
µ (µ + ω )
⇒ A0 = µ ( µ + ω )( µ + σ )( µ + ξ + γ ) − σβ ∧ ω − σβ ∧ µ + σβρξ
= µ ( µ + ω )( µ + σ )( µ + ξ + γ ) + σβρξ − σβ ∧ (ω + µ )
= ( µ + ω ) [ µ ( µ + σ )( µ + ξ + γ )] + σβρξ > 0
A 0
H = 1
A0 A2
24 Opara Chiekezi Zephaniah et al.: A Mathematical Model and Analysis of an SVEIR Model for Streptococcus
Pneumonia with Saturated Incidence Force of Infection
With
H1 = A1 = A1 > 0
A 0
H2 = 1 = A1 A2 > 0
A0 A2
This therefore shows that all the eigenvalues of the Jacobian of the system have negative real parts. Hence, the DFE is
locally asymptotically stable.
3.6. Global Stability of Disease-free Steady State
Theorem 3.4: If R0 ≤ 1 for the model (4) then the infection-free equilibrium state (ξ 0 ) is the only non-negative equilibrium
state of the model (4) and it is globally asymptotically stable.
Proof:
Let L = c1 E + c2 I be the Lyapunov function, where c1 and c2 are constants
dL dE dI
= c1 + c2 (*)
dt dt dt
dL σ dE 1 dI
⇒ = +
dt ( µ + σ )( µ + ξ + γ ) dt µ + ξ + γ dt
σ
[ λβ SI + λβ (1 − ξ )VI − ( µ + σ ) E ] +
1
=
( µ + σ )( µ + ξ + γ ) (µ + ξ + γ )
[σ E − (µ + ξ + γ ) I ]
σ σE σE
=
( µ + σ )( µ + ξ + γ )
[λβ SI + λβ (1 − ξ )VI ] − ( µ + ξ + γ ) + (µ + ξ + γ ) − I
At the D. F. E λ = 1
dL σβ ∧ω + ∧ µ (1 − ρ ) (1 − ξ ) ∧ ρ
⇒ = + I −I
dt ( µ + σ )( µ + ξ + γ ) µ ( µ + ω ) (µ + ω )
dL σβ ∧ [ω + µ (1 − ρξ ) ] I
= −I
dt µ ( µ + σ )( µ + ω )( µ + ξ + γ )
But dL
R+5 except the points where =0
dt
σβ ∧ [ω + µ (1 − ρξ )]
= R0 By Lyapunov-Lasalle asymptotic stability theorem, this
µ ( µ + σ )( µ + ω )( µ + ξ + γ ) implies that the largest invariant set of the system is globally
asymptotically stable.
dL The global stability of the D. F. E. state means that; any
⇒ = R0 I − I
dt initial level of S. pneumonia infection, the infection will
dL
= I ( R0 − 1) gradually die out from the population when R0 ≤ 1 .
dt
dL
R0 > 1 means that one infected individual living in an
≤ I ( R0 − 1) entirely Susceptible population will cause an average more
dt
than one infected individual in the next generation; in this
Hence by Lyapunev-Lasalle asymptotic stability theorem in case, S. pneumonia invades such a population and persists.
[24], when R0 ≤ 1 it implies that the disease-free equilibrium Basic reproduction rate R0 is greater than 1 implies that
state ( E * ) is globally asymptotically stable in R+5 . the D. F. E. is unstable.
Because ( E * ) is the only point in R5 where dL = dN = 0 3.7. Global Stability of Endemic Steady State
dt dt
that is the derivatives of both N and L are equal to zero, Theorem 3.4: The unique endemic equilibrium of mode (1)
then is ( E * ) unique. given by E** is globally asymptotically stable in Ω if
This completes the proof. R0 > 1.
dL Proof:
Remarks: R0 ≤ 1 implies that < 0 holds everywhere in
dt Consider the following non-linear Lyaponuv function
Mathematical Modelling and Applications 2020; 5(1): 16-38 25
S E V I
L = c1 S − S ** − S ** ln ** + E − E ** − E ** ln ** + c2 V − V ** − V ** ln ** + c3 I − I ** − I ** ln **
S E V I
dL S ** * E ** * V ** * I ** *
= c1 1 − S + 1 − E + c2 1 − V + c3 1 − I
I
dt S E V
S ** E **
( (1 − ρ ) ∧ +ωV + ρ R − λβ SI − µ S ) + 1 − ( λβ SI + λβ (1 − ξ ) VI − ( µ + ω ) E )
dL
= c1 1 −
dt S E
V **
+ c2 1 −
( ρ ∧ −λβ (1 − ξ ) VI − ( µ + ω ) V )
V
I **
+ c3 1 −
(σ E − ( µ + ξ + γ ) I )
I
(1 − ρ ) ∧ = λβ S ** I ** − ωV ** − ρ R** + µ S **
ρ ∧ = λβ (1 − ξ ) V ** I ** + ( µ + ω ) V **
S ** E **
dL
= c1 1 −
S
λβ (
S ** I ** − ωV ** − ρ R** + µ S ** + ωV + ρ R − 2β SI − µ S + 1 −
E
( λβ )
SI + λβ (1 − ξ ) VI − ( µ + ω ) E )
dt
V **
+ c2 1 −
V
(
λβ (1 − ξ ) V I + ( µ + ω ) V − λβ (1 − ξ )VI − ( µ + ω ) V
** ** **
)
I **
+ c3 1 −
I
(σ E − ( µ + ξ + γ ) I )
Collecting all the terms without ** in the infected classes and equating them to zero ( 0 )
Letting
−c1λβ SI − c1λβ S ** I + c1λβ (1 − ξ ) VI − c2 λβ (1 − ξ ) VI + c2 λβ (1 − ξ )V ** I + c3σ E = 0
c1 λβ (1 − ξ ) V + λβ S ** + c2 λβ (1 − ξ ) V ** − λβ (1 − ξ )V I
λβ (1 − ξ )V − λβ (1 − ξ ) V ** c2
c1 =
λβ (1 − ξ ) V + S **
(1 − ξ ) (V − V ** ) c2
c1 =
(1 − ξ )V + S **
c2 = (1 − ξ ) V + S ** ⇒ c1 = (1 − ξ ) V − V ** ( )
Also
26 Opara Chiekezi Zephaniah et al.: A Mathematical Model and Analysis of an SVEIR Model for Streptococcus
Pneumonia with Saturated Incidence Force of Infection
c3σ E = 0; σ ≠ 0 ⇒ c3 = 0
(
) S E V
L = (1 − ξ ) V − V ** S − S ** − S ** ln ** + E − E ** − E ** ln ** + (1 − ξ ) V + S ** V − V ** − V ** ln **
S E
V
* S ** * * E ** * * V ** * * V ** *
dL
(
= (1 − ξ ) V − V ** S − ) S + E− E + (1 − ξ ) V V − V + S ** V − V
dt S E V V
*
* S ** * * E ** * V ** *
* S ** * * E ** * * V ** *
= (1 − ξ ) V S − S + E− E +V − V − (1 − ξ ) V ** S − S + E− E + S ** V − V
S E V
S E V
S **
(1 − ρ ) ∧ +ωV + ρ R − λβ SI − µ S −
S
( (1 − ρ ) ∧ +ωV + ρ R − λβ SI − µ S )
E **
= (1 − ξ ) V +λβ SI + λβ (1 − ξ ) VI − ( µ + σ ) E −
E
( λβ SI − λβ (1 − ξ ) VI − ( µ + σ ) E )
**
+ ρ ∧ −λβ (1 − ξ ) VI − ( µ + ω ) V −
V
( ρ ∧ −λβ (1 − ξ ) VI ( µ + ω ) V )
V
S **
(1 − ρ ) ∧ +ωV + ρ R − λβ SI − µ S − ( (1 − ρ ) ∧ +ωV + ρ R − λβ SI − µ S )
− (1 − ξ ) V **
S
E **
+λβ SI + λβ (1 − ξ )VI − ( µ + σ ) E −
E
( λβ SI + λβ (1 − ξ ) VI − ( µ + σ ) E )
**
+ S ** ρ ∧ −λβ (1 − ξ ) VI − ( µ + ω ) V −
V
( ρ ∧ −λβ (1 − ξ ) VI − ( µ + ω ) V )
V
λβ S ** I ** − ωV ** − ρ R** + µ S ** + ωV + ρ R − λβ SI − µ S
**
S
( )
− S λβ S I − ωV − ρ R + µ S + ωV + ρ R − λβ SI − µ S + λβ SI + λβ (1 − ξ ) VI − ( µ + σ ) E
** ** ** ** **
= (1 − ξ ) E **
− ( λβ SI + λβ (1 − ξ ) VI − ( µ + σ ) E ) + λβ (1 − ξ ) V I + ( µ + ω )V − λβ (1 − ξ ) VI − ( µ + ω ) V
** ** **
E
V **
−
V
(
λβ (1 − ξ ) V I + ( µ + ω ) V − λβ (1 − ξ ) VI − ( µ + ω ) V
** ** **
)
λβ S ** I ** − ωV ** − ρ R** + µ S ** + ωV + ρ R − λβ SI − µ S
**
** S
− (1 − ξ ) V −
S
(
λβ S I − ωV − ρ R + µ S + ωV + ρ R − λβ SI − µ S
** ** ** ** **
)
**
+λβ SI + λβ (1 − ξ ) VI − ( µ + σ ) E − E ( λβ SI + λβ (1 − ξ ) VI − ( µ + σ ) E )
E
λβ (1 − ξ ) V ** I ** + ( µ + ω ) V ** − λβ (1 − ξ ) VI − ( µ + ω ) V
+ S ** V **
−
V
(
λβ (1 − ξ ) V ** I ** + ( µ + ω ) V ** − λβ (1 − ξ ) VI − ( µ + ω ) V )
µ S ** , ( µ + σ ) E, ( µ + σ ) E** , ( µ + ω )V
Collecting all the terms with ** in the infected classes including all the and
( µ + ω )V **
Mathematical Modelling and Applications 2020; 5(1): 16-38 27
2
VS ** **
2
V ** S ** ** V ** S ** **
2
λβ VS I − λβ
** **
I + λβ I − λβ I
= (1 − ξ ) S S V
+λβ (1 − ξ ) VV I − λβ (1 − ξ ) V I
** ** **2 **
E **
E **
E **
E **
+ (1 − ξ ) λβ SV ** I − λβ SIV + λβ (1 − ξ ) VV ** I − λβ (1 − ξ ) V 2 I
E E E E
V µ S **
2
µV ** S **
2
+ (1 − ξ ) 2V µ S ** − V µ S − − 2µV ** S ** − µV ** S −
S
S
( )
+ (1 − ξ ) V ( µ + σ ) E ** − E + V ** ( µ + σ ) E − E **
(
)
( )
**2 **
+ (1 − ξ ) ( µ + ω ) 2VV − V − V **2 ** V S
(
** 2
+ µ + ω ) 2 S V − VS −
** **
V
V V S ** S ** V ** V V **
= λβ (1 − ξ ) S **V ** I ** ** − ** + − + (1 − ξ ) ** − (1 − ξ ) **
V V S S V S S
V ** V ** V E **
+ λβ (1 − ξ ) SVI − 1 + (1 − ξ ) − (1 − ξ )
V S S E
S S S ** ** E
+ µ (1 − ξ ) VS ** 2 − ** − µ (1 − ξ ) V ** S ** 2 − ** − + (1 − ξ )( µ + σ ) VE 1 − **
S S S E
V V ** ** ** V V **
+ (1 − ξ )( µ + σ )V ** E ** 2 − ** − + ( µ + ω ) V S 2 − ** −
V V V V
V (1 − ξ )V **
(1 − ξ ) − =0
S ** S **
And
V ** V
(1 − ξ ) − (1 − ξ ) = 0
S S
Hence we have
dL S S ** ** ** S ** S
≤ µ (1 − ξ ) VS ** 2 − ** − − µ (1 − ξ ) V S 2 − − **
dt S S S S
E E
+ (1 − ξ )( µ + σ ) VE ** 1 − ** + (1 − ξ )( µ + σ ) V ** E ** ** − 1
E E
V V ** ** ** V V **
+ (1 − ξ )( µ + ω ) VV ** 2 − ** − + ( µ + ω ) V S 2 − **
V V V V
Finally, since the arithmetic mean exceeds the geometric mean, then
S ** S
2 − − ** ≤ 0
S S
V
2 − V − ** ≤ 0
V
Furthermore, since all the model parameters are non-negative, it follows that
28 Opara Chiekezi Zephaniah et al.: A Mathematical Model and Analysis of an SVEIR Model for Streptococcus
Pneumonia with Saturated Incidence Force of Infection
dL
≤ 0 for R0 > 1. Thus L is aLyapunov function of system (4) on Ω .
dt
Therefore, it follows from Lasalle’s Invariance Principle that
lim S ( t ) = S **
t →∞
lim V ( t ) = V **
t →∞
lim E ( t ) = E**
t →∞
lim I ( t ) = I **
t →∞
lim R ( t ) = R**
t →∞
Where u0 ( x) is an initial approximation with possible unknowns, λ is the Lagrange multiplier which can be determined
optimally via variational theory, the subscript k denotes the k th approximation and uɶk is considered as a restricted variation
such that δ uɶk = 0 . It is shown that this method is very effective and easy for a linear problem, its exact solution can be obtained
by only the first iteration because λ can be exactly identified.
Hence to solve the above equation, we proceed by considering the stationary condition of the correction functional, then the
Lagrange multiplier λ becomes,
( −1) m
λ (s) = ( s − x) m −1 (21)
( m − 1)!
t ( −1) m
uk +1 ( x) = uk ( x) + ∫ 0 ( m − 1)!
( s − x) m −1 L[uk ( s )] + N [uɶk ( s )] −ψ ( x) ds (22)
t dS n β Sɶn Iɶn
S n +1 = S n + ∫ λ (t ) dt
0
1 − (1 − p ) Λ − ωVn − ρ Rn +
1+α I
+ µ S n dt
(23)
t dVn β (1 − ξ ) I nVn
Vn +1 = Vn + ∫ λ (t ) dt
0
2 − pΛ +
1+α I
+ (ω + µ )Vn dt
(24)
t dEn β I n S n β (1 − ξ ) I nVn
En +1 = En + ∫ λ (t )
0
3
dt
−
1+ α I
−
1+α I
+ (σ + µ ) En dt
(25)
Mathematical Modelling and Applications 2020; 5(1): 16-38 29
t dI n
I n +1 = I n + ∫ λ (t ) dt
0
4 − σ En + ( µ + ε + γ ) I n dt
(26)
t dRn
Rn +1 = Rn + ∫ λ (t ) dt
0
5 − γ I n + ( ρ + µ ) Rn dt
(27)
Where λi , i = 1, 2,...5 are the Lagrangemultiplier which can be identified optimally via variational Theory.
we now obtain the optimal values of λi
( −1) m
λi (t ) = (t − x) m −1 , i = 1, 2, 3, 4, 5 (28)
( m − 1)!
( −1)1 −1
λ1 (t ) = (t − S )1−1 = (t − S ) 0 = − 1
(1 − 1)! 0!
( −1)1 −1
λ2 (t ) = (t − V )1−1 = (t − V )0 = − 1
(1 − 1)! 0!
( −1)1 −1
λ3 (t ) = (t − E )1−1 = (t − E )0 = − 1
(1 − 1)! 0!
( −1)1 −1
λ4 (t ) = (t − I )1−1 = (t − I ) 0 = − 1
(1 − 1)! 0!
( −1)1 −1
λ5 (t ) = (t − R )1−1 = (t − R ) 0 = − 1
(1 − 1)! 0!
t dS β Sɶn Iɶn
S n +1 = S n − ∫ dt
0
n
− (1 − p ) Λ − ωVn − ρ Rn +
1+α I
+ µ S n dt
(29)
t dVn β (1 − ξ ) I nVn
Vn +1 = Vn − ∫ dt
0
− pΛ +
1+α I
+ (ω + µ )Vn dt
(30)
t dEn β I n S n β (1 − ξ ) I nVn
En +1 = En − ∫
0 dt
−
1+α I
−
1+α I
+ (σ + µ ) En dt
(31)
t dI n
I n +1 = I n − ∫ λ (t ) dt
0
4 − σ En + ( µ + ε + γ ) I n dt
(32)
t dRn
Rn +1 = Rn − ∫ λ (t ) dt
0
5 − γ I n + ( ρ + µ ) Rn dt
(33)
S1 ( t ) = 25 + 7.57218t
V1 ( t ) = 20 + 1.8944104t
E1 ( t ) = 15 + 0.4470096 t
I1 ( t ) = 10 − 3.8516 t
R1 ( t ) = 0.714 t
In this section, we determine the solution of model (4) using Adomain Decomposition Method (ADM).
Let us consider system (4) in an operator form;
LS = (1 − ρ )Λ + ωΛ + ρΛ − λβ SI − µ S
LV = ρΛ − λβ (1 − ξ )VI − ( µ + ω )V
LE = λβ SI + λβ (1 − ξ )VI − ( µ + σ ) E
(34)
LI = σ E − ( µ + ε + γ ) I
LR = γ I − ( µ + ρ ) R
d
where L =
dt
t t t t
0
∫0 0
∫
S (t ) = S (0) + (1 − p)Λt + ω Vdt +ρ Rdt − λβ SIdt − µ Sdt
0
∫ ∫
t t
0
∫
V (t ) = V (0) + pVt − λβ (1 − ξ ) VIdt − ( µ + ω ) Vdt
0
∫
t t t (35)
0
∫ 0
∫
E (t ) = E (0) + λβ SIdt + λβ (1 − ξ ) VIdt − ( µ + σ ) Edt
0
∫
t t
I (t ) = I (0) + σ Edt − ( µ + ε + γ ) Idt
∫ ∫
0 0
t t
0
∫
R (t ) = R (0) + γ Idt − ( µ + ρ ) Rdt
0
∫
Applying Adomain Decomposition Method, the solution of the equation (35) above becomes sum of the following series;
The linear terms
∞ ∞ ∞ ∞ ∞
S= ∑
n=0
S n ;V = ∑
n =0
Vn ; E = ∑
n =0
En ; I = ∑
n =0
In ; R = ∑E
n=0
n
∞
VI = ∑ B (V ,...,V ; I ,..., I )
n =0
n 0 n 0 n
Where
∞ ∞
dn
1 n =0
Sk λ k
∑ Ik λ k
∑
An = n =0
λ =0 (36)
n! dλn
and
∞ ∞
dn
1
∑
n=0
Sn λ k
∑
n=0
Inλ k
Bn = (37)
n! dλk
λ =0
∫ ∫ ∫
Sn +1 = ω Vn dt + ρ Rn dt − λβ An dt − µ Sn dt
0 0 0
∫
0
t t
∫
Sn +1 = λβ (1 − ξ ) Bn dt − ( µ + ω ) Vn dt
0
∫
0
t t t
∫
0
∫
En +1 = λβ An dt + λβ (1 − ξ ) Bn dt − ( µ + σ ) En dt
0
∫
0
(38)
t t
∫ ∫
I n +1 = σ En dt − ( µ + ξ + r ) I n dt
0 0
t t
∫ ∫
Rn +1 = r I n dt − ( µ + ρ ) Rn dt
0 0
A0 = S0 I 0
A1 = S0 I1 + S1 I 0
A2 = S0 I 2 + S1 I1 + S2 I 0
A3 = S0 I 3 + S1 I 2 + S2 I1 + S3 I 0
A4 = S0 I 4 + S1 I 3 + S2 I 2 + S3 I1 + S4 I 0
A5 = S0 I 5 + S1 I 4 + S2 I 3 + S3 I 2 + S4 I1 + S5 I 0
B0 = V0 I 0 ,
B1 = V0 I1 + V1 I 0
B2 = V0 I 2 + V1 I1 + V2 I 0
B3 = V0 I 3 + V1 I 3 + V2 I 2 + V3 I1 + V4 I 0
B4 = V0 I 5 + V1 I 4 + V2 I 3 + V3 I 2 + V4 I1 + V5 I 0
S1 = 0.8926t + 0.059216635t 2
V1 = −1.5160096t + 0.1.1292557365t 2
E1 = 0.4470098t + 0.06903010054t 2
I1 = −3.85160t
R1 = 0.7140t
S2 = 3.368814965t 2 + 0.008862406378t 3
V2 = 0.1094555764t 2 + 0.009177100611t 3
E2 = −0.1249025142t 2 − 0.01829162969t 3
I 2 = 0.7758508926t 2 + 0.0002521899673t 3
R2 = −3.493373520t 2
Mathematical Modelling and Applications 2020; 5(1): 16-38 33
Figure 5. Plot of Exposed Pop against time. Figure 8. Susceptible Popu. Againsttime.
Figure 12. Plot of Infected population against time for different values α.
Figure 13. Plot of Infected population aginst time for different values of ω.
Figure 14. Plot of Infected population against time for different values of Λ.
Our simulation in the two graphs above, we observed that 5. Summaries, Conclusion and
ω and Λ little or no variation in the infected population. The
implication of this is that as more individuals with high Recommendation
proportion of antibody against S. pneumonia is recruited into
5.1. Summary
the population, there is no need vaccinating them again, since
their immune system is already in fighting against S. In this paper, the dynamics of SVEIR model with saturated
pneumonia. That is to say that an individual needs incidence force of infection and saturated vaccination
vaccination before he/she will be introduced into the function for Streptococcus pneumonia (that is, model that
population. Also, we see from the simulation above that monitors the temporal transmission dynamics of the disease
increase in recovery rate γ reduces the number of infected in the presence of preventive vaccine) was formulated and
individual over time. analyzed. The basic reproduction number that determines
disease extinction and disease survival was revealed. The
existing threshold conditions of all kinds of the equilibrium
points are obtained and proved to be locally asymptotic
stable for disease-free equilibrium using linearization method
and Lypanov functional method for Endemic equilibrium.
Qualitative Analysis of the model was obtained and the
positive of solution obtained. It was revealed that the model
is positively –invariant and attracting. Thus Ω is positively
invariant. Hence, it is sufficient to consider the dynamics of
the model (1) in Ω . In this region, the model can be
considered as been epidemiologically and mathematically
well-posed, Hethcote (2000). The governing model was
normalized and also Adomain Decomposition method was
used to compute an approximate solution of the non-linear
system of differential equations governing the model. Maple
was used in carrying out the simulations (numerical solutions)
of the model. Graphical results were presented and discussed
Figure 16. Plot of Population against time for VIM. to illustrate the solution of the problem. The achieved results
reveal that the disease will die out within the community if
the vaccination coverage is above the critical vaccination
proportion. The study indicates that we should improve the
efficiency and enlarge the capacity of the treatment to control
the spread of disease.
5.2. Conclusion
It is revealed that the DFE is globally asymptotically stable
while the endemic equilibrium is not feasible which implies
that the disease will be eradicated out of the population If
ℜ0 < 1, . Furthermore, we can also see that if ℜ0 > 1 and
H > 0 , then endemic equilibrium is globally asymptotically
stable. In order to regulator the disease, it will be strategical
to decrease the BRN to barest minimum. From the
manifestation of BRN ℜ0 , it is obvious that the rate ξ
representing vaccine efficiency, the rate/transfer of individual
Figure 17. Plot of Population against time for ADM.
out of the infected compartment ν i− and (1 − ξ ) revealing the
Figure 16 and Figure 17 shows the simulation for the rate at which the vaccine get waned directly or indirectly
Variational iteration Method (VIM) and Adomian impact the value of ℜ0 . Obviously, if ξ , ν i− or (1 − ξ )
Decomposition method (ADM) respectively. It was seen that increase, implies ℜ0 decreases. Therefore, the need for
in Figure 15, within the first 3 days the infection is still in the
public health interventions to control the epidemic by
population until, the 4th day when the number of infected
ensuring these parameters ξ , ν i− or (1 − ξ ) are increased to
individual is reduced to zero. While Figure 17 shows that
from the 1st day the infection is completely out of the reduce ℜ0 can never be over emphasis.
population. Hence, it shows that the ADM converges faster
than the VIM. 5.3. Recommendation
irrespective of high use of the 7-valent pneumococcal conjugate [6] Centers for Disease Control and Prevention (2017)
vaccine (PCV7) in Nigeria and other African countries. “Streptococcus pneumonia” Published on official website
https://www.cdc.gov/pneumococcal/clinicians/streptococcus-
The epidemiology of human population especially those pneumoniae.html.
concerning under age children requires urgent and serious
investigation so as to understand the diseases and proffer [7] Diftz K., Schenzle D. Proportionate mixing models for age-
solutions that will completely eradicate it from our dependent infection transmission J. Math. Biol., 22 (1985):
117-120.
population. This could be achieved through
1. International partnership and research collaboration. [8] Donnelly C. A. (2003) Epidemiological determinants of
2. Improve funding of epidemiological research programs. spread of causal agent of severe acute respiratory syndrome in
3. Advocacy and awareness creation among rural and Hong Kong, The Lancet Published online May 7, 2003.
urban communities. [9] Dulpl, E. (2012) Nasopharyngeal carrier rate of Streptococcus
4. Efficient and effective specialist vaccination centers in pneumonia in children: serotype distribution and antimicrobial
rural and urban communities. resistance. Archieves of Iranian Medicine 15: 500.
5. Free and effective vaccination of under age children. [10] Eckalbar J. C &Eckalbar W. L. (2011) Dynamics of an
Thus the need for a greater understanding of Streptococcus epidemic model with quadratic treatment. Nonlinear Analysis:
Pneumonia and for more effective vaccination, treatment and Real World Applications. 2011; 12 (1): 320–332.
control program is paramount to eradication of the infection.
[11] Esteva L & Matias M. (2001) A model for vector transmitted
Therefore, we consent the effort of the US Food and Drug diseases with saturation incidence. Journal of Biological
Administration (February 24, 2010) that licensed a new 13- Systems. 2001; 9 (4): 235–245.
valent pneumococcal polysaccharide-protein conjugate
vaccine (PCV13) for under age children. [12] Faden, H., Duffy, L., Wasielewski, R., Wolf, J., Krystofik, D.
& Tung, Y. (1997) Relationship between nasopharyngeal
Hence we would also recommend from the above knowledge: colonization and the development of otitis media in children.
1. Healthy children and their counterparts (both those who Journal of Infectious Diseases 175: 1440-1445.
have completed the previous vaccine PCV7) with other
health challenging issues exposing them to high risk of [13] Falade, A. G. & Ayede, A. I. (2011) Epidemiology, aetiology
and management of childhood acute community-acquired
IPD should be routinely immunize with PCV13. pneumonia in developing counties - a review. African Journal
2. “Catch-up” immunization should be conducted for of Medicine and Medical Sciences 40: 293-308.
children behind schedule; and,
3. There should be timely treatment and vaccination for [14] Hethcote H. (2000) The Mathematics of Infectious Diseases;
SIAM Review; 42 (4): 599–653.
infected individuals and those with compromised
immunity including newborn babies respectively. [15] Hethcote H., Zhien M, Shengbing L., (2002) “Effects of
quarantine in six endemic models for infectious diseases
Mathematical Biosciences, 180 (2002): 141-160,
10.1016/S0025-5564(02)00111-6.
References
[16] He, J. H. (1999). Variational iteration method- a kind of non-
[1] Acedo L, Gonzalez-Parra G, &Arenas A. (2010) An exact linear analytical technique: some examples, Int. J. Nonlin.
global solution for the classical Epidemic model; Nonlinear Mech., 34: 699-708.
Analysis: Real World Applications; 11 (3): 1819–1825.
[17] He, J. H. & X. H. Wu (2006). Construction of solitary
[2] Alexander M. E, & Moghadas S. M. (2005) Bifurcation solutions and compacton-like solution by variational iteration
analysis of SIRS epidemic model with method, Chos. Soltn. Frcts; 29 (1): 108-113.
generalizedIncidence, SIAM Journal on Applied
Mathematics, 65 (5): 1794–181. [18] Hoppensteadt F. (1974) “An Age Dependent Epidemic Model”
Journal of the Franklin Institute 297 (5): 325-333.
[3] Batt, S. L., Charalambous, B. M., Solomon, A. W., Knirsch,
C., Massae, P. A., Safari, S., Sam, N. E., Everett, D., Mabey, [19] Hoppensteadt F. (1974) Asymptotic stability in singular
D. C. & Gillespie, S. H. (2003) Impact of azithromycin perturbation problems J. Diff. Eq, 15 (no. 3): 510-521.
administration for trachoma control on the carriage of
antibiotic-resistant Streptococcus pneumoniae. Antimicrobial [20] Jacobs, M. R. (2004) Streptococcus pneumoniae:
Agents and Chemotherapy 47: 2765-2769. Epidemiology and patterns of resistance. American Journal of
Medicine Supplements117: 3-15.
[4] Blossom, D. B., Namayanja-Kaye, G., Nankya-Mutayoba, J.,
Mukasa, J. B., Bakka, H., Rwambuya, S., Windau, A., [21] Joloba, M., Bajaksouzian, S., Plalavecino, E., Whalen, C. &
Bajaksouzian, S., Walker, C. J. & Joloba, M. L. (2006) Jacobs, M. (2001a) High prevalence of carriage of antibiotic-
Oropharyngeal colonization by Streptococcus pneumonia resistant Streptococcus pneumoniae in children in Kampala,
among HIV-infected adults in Uganda: assessing prevalence Uganda. International Journal of Antimicrobial Agents 17:
and antimicrobial susceptibility. International Journal of 395-400.
Infectious Diseases 10: 458-464.
[22] Kinabo G. D, Van der Ven A, Msuya, Shayo A. M, Schimana
[5] Bogaert, D., De Groot, R. & Hermans, P. (2004) W, Ndaro A, Van Asten H, Dolmans W, Warris A, &
Streptococcus pneumonia colonization: the key to Hermans P (2013) Dynamics of nasopharyngeal bacterial
pneumococcal disease. Lancet Infectious 4: 144-154. colonization in HIV exposed young infant in Tanzania; 18 (3):
286-295.
Mathematical Modelling and Applications 2020; 5(1): 16-38 39
[23] Korobeinikov, A. (2004) Lyapunov functions and global unvaccinated nursing rome residents. N. Engl. J. Med. 338:
properties for SEIR and SEIS epidemic models; Math. Med. 1861–1868. Doi: 10.1056/NEJM199806253382601.
Biol.: J. IMA., 21: 75-83.
[36] O’Brien, K. L., Wolfson, L. J., Watt, J. P., Henkle, E.,
[24] La Salle J. P. (1976) The Stability of Dynamical Systems, Deloria-Knoll, M., McCall, N., Lee, E., Mulholland, K.,
SIAM, No. 25. Levine, O. S. & Cherian, T. (2009) Burden of disease caused
by Streptococcus pneumoniae in children younger than 5
[25] Lannelli M, Martcheva M, & Li X.-Z., (2005) “Strain years: global estimates. Lancet 374: 893-902.
replacement in an epidemic model with super-infection and
perfect vaccination,” Mathematical Biosciences, 195 (1): 23– [37] Prina, E., Ranzani, O. T., & Torres, A. (2015b). Community-
46, 2005. View at Publisher View at Google Scholar View at acquired pneumonia; Lancet 386: 1097–1108. doi:
MathSciNet · View at Scopus. 10.1016/S0140-6736(15)60733-4.
[26] Li M. Y, &Muldowney J. S. (1996) A geometric approach to [38] Schrag, S. J., Peña, C., Fernández, J., Sánchez, J., Gómez, V.,
global-stability problems. SIAM Journal onMathematical Pérez, E., et al. (2001). Effect of short-course, high-dose
Analysis; 27 (4): 1070–1083. amoxicillin therapy on resistant pneumococcal carriage: a
randomized trial. JAMA 286: 49–56. Doi:
[27] Li, J., and Brauer, F. (2008). “Continuous-time age-structured 10.1001/jama.286.1.49. Available online at:
models in population dynamics and epidemiology,” in Math http://jamanetwork.com/journals/jama/fullarticle/193977.
Epidemiol, Lecture Notes in Mathematics, eds. F. Brauer, P.
van den Driessche, and J. Wu (Berlin; Heidelberg: Springer), [39] Shrestha, S., Foxman, B., Dawid, S., Aiello, A. E., Davis, B.
1945: 205–227. M., Berus, J., et al. (2013). Time and dose-dependent risk of
pneumococcal pneumonia following influenza: a model for
[28] Li, Y. (2004). Determination of the critical concentration of within-host interaction between influenza and Streptococcus
neutrophils required to block bacterial growth in tissues. J. pneumoniae. Interf. Focus 10: 20130233. doi:
Exp. Med. 200: 613–622. doi: 10.1084/jem.2004072. 10.1098/rsif.2013.0233.
[29] Liu, X. B, &Yang, L. J. (2012) Stability analysis of an [40] Smith, A. M., Adler, F. R., Ribeiro, R. M., Gutenkunst, R. N.,
SEIQV epidemic model with saturated incidence rate. McAuley, J. L., McCullers, J. A., et al. (2013). Kinetics of
Nonlinear Analysis: Real World Applications; 13 (6): 2671– coinfection with influenza A virus and Streptococcus
2679. pneumoniae. PloSPathog. 9:e1003238. Doi:
10.1371/journal.ppat.1003238.
[30] Mochan, E., Swigon, D., Ermentrout, B., Lukens, S., &
Clermont, G. (2014). A mathematical model of intrahost [41] Smith, A. M., McCullers, J. A., & Adler, F. R. (2011).
pneumococcal pneumonia infection dynamics in murine Mathematical model of a three-stage innate immune response
strains; J. Theoritical Biol. 353: 44–54. doi: to a pneumococcal lung infection; J. Theoritical Biology 276:
10.1016/j.jtbi.2014.02.021. 106–116. doi: 10.1016/j.jtbi.2011.01.052.
[31] McCullers, J. A., English, B. K., & Novak, R. (2000). [42] Van den Driessche & Watmough J. “Reproduction numbers
Isolation and characterization of vancomycin-tolerant and sub-threshold endemic equilibria for compartmental
Streptococcus pneumoniae from the cerebrospinal fluid of a models of disease transmission”; Mathematics Biosciences,
patient who developed recrudescent meningitis; J. Infect. Dis. 180 (2): 29-48.
181: 369–373. Doi: 10.1086/315216.
[43] Wang W. & Ruan S. (2004), Simulating the SARS outbreak in
[32] MurrayJ. D. (2001) Mathematical Biology (2nd, corrected Beijing with limited data, J. Theoretical Biology227: 369-379.
Edition), Springer-Verlag, pp. 385-396.
[44] Xu, R. (2012) Global stability of a delayed epidemic model
[33] Nantanda, D. M., Hildenwall, H., Peterson, S., Kaddu- with latent period and vaccination strategy Appl. Math. Model,
Mulindwa, D., Kalyesubula, I. &Tumwine, J. K. (2008) 36: 5293-5300.
Bacterial aetiology and outcome in children with severe
pneumonia in Uganda. Annals of Tropical Paediatrics: [45] Zhang X, & Liu X. N. (2008) Backward bifurcation of an
International Child Health 28: 253-260. epidemic model with saturated treatment function. Journal of
Mathematical Analysis and Applications; 348 (1): 433–443.
[34] Nelson, P. W., Gilchrist, M. A., Coombs, D., Hyman, J. M., &
Perelson, A. S. (2004). An age-structured model of HIV [46] Zhou L, & Fan M. (2012) Dynamics of an SIR epidemic
infection that allows for variations in the death rate of model with limited medical resources revisited. Nonlinear
productively infected cells; Math. Bioscience 1: 267–288. Doi: Analysis: Real World Applications; 13 (1): 312–324.
10.3934/mbe.2004.1.267.
[47] Omame, A., Okuonghae, D., Umana, R. A., Inyama, S. C.,
[35] Nuorti, P., Butler, J. C., Crutcher, J., Guevara, R., Welch, D., (2019) Analysis of a co-infection model for HPV-TB, Applied
Holder, P., et al. (1998). An outbreak of multidrug- Mathematical Modelling,
resistantant pneumococcal pneumonia and bacteremia among https://doi.org/10.1016/j.apm.2019.08.012.